Qualigen Therapeutics Inc. (AIXC)
NASDAQ · Healthcare
Qualigen Therapeutics Inc. Income Statement 2020–2022
| Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 5.0M | 5.7M | 4.3M | 5.6M |
| Gross Profit | — | 689,236 | 629,517 | — |
| Profitability | ||||
| Operating Income | -14.8M | -22.7M | — | -1.5M |
| EBITDA | -14.7M | -22.5M | — | -1.3M |
| Net Income | -18.6M | -17.9M | -20.4M | -1.8M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 4M | 4M | 27M | 46M |
Qualigen Therapeutics Inc. Income Statement — FAQ
Qualigen Therapeutics Inc. (AIXC) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIXC's income statement history?
The chart and table above show Qualigen Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.